RefluxStop® Gains Momentum at DDW 2026
Implantica AG showcased its innovative RefluxStop® device for acid reflux treatment at Digestive Disease Week (DDW) 2026, where independent surgeon Dr. Yves Borbély presented positive long-term safety and efficacy outcomes. The RefluxStop® device, which offers a unique surgical solution for GERD, garnered significant attention from healthcare professionals, highlighting its potential benefits over traditional anti-reflux surgeries. Dr. Peter Kahrilas and Dr. John Lipham expressed optimism about its FDA approval and its ability to improve treatment options for GERD patients.
VADUZ, Liechtenstein, May 19, 2026 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field with 1 billion sufferers,…